Reviewed July 28, 2026
Is KPV Legal? FDA Status and Licensed Care Options
A committee recommendation is not FDA approval. Here is exactly what changed, and what did not.
The short answer
- FDA status
- Not an FDA-approved drug product
- July 2026 vote
- Advisory committee recommended for the 503A bulks list process
- Reviewed for
- Wound healing and inflammatory conditions
- Prescriber
- Required. Available only through a licensed clinician.
The committee recommended this compound continue in the process that could allow licensed 503A pharmacies to compound it. The FDA has not acted yet. It is not an approved drug, and a recommendation is not permission to purchase it.
Why “is it legal” has no yes-or-no answer
For peptides, access is not a single switch. It depends on the FDA status of the substance, whether a compounding pathway applies, what your state’s pharmacy and medical boards permit, and whether a licensed clinician has evaluated you and written a prescription. Any source giving you a flat yes or no is skipping at least three of those.
KPV is far less known to consumers than BPC-157, which changes the risk. Most people searching for it have already been told about it by a clinic or a forum rather than an advertisement, and there is very little independent consumer information to check that claim against.
What the advisory committee actually reviewed
The committee looked at KPV in the context of wound healing and inflammatory conditions. 'Inflammatory conditions' is a broad clinical category, and that breadth is exactly where marketing tends to overreach - a specific reviewed context can be stretched to cover almost any complaint if nobody is checking.
A broad inflammation claim may not match the reviewed context.
What a committee recommendation is — and is not
The Pharmacy Compounding Advisory Committee advises the FDA. Its recommendations can shape what the agency does next, but the FDA is not required to follow them, and a recommendation is not a drug approval, a safety finding, a prescription, or proof that any clinic can offer something today. The FDA meeting record and the 503A bulk drug substances page are the authoritative sources.
Questions people ask
What did the advisory committee decide about KPV?
It recommended KPV continue in the 503A bulks list process. That is a step in a regulatory process, not FDA approval.
Is KPV an approved drug?
No. It is not an FDA-approved drug product. Any access path involves a licensed prescriber and a licensed compounding pharmacy.
A clinic told me KPV treats my inflammation. Is that accurate?
The committee reviewed KPV for wound healing and inflammatory conditions in a clinical sense. That does not mean it has been shown to help a particular person's condition. Ask what evidence applies to your specific situation.
Is there less information about KPV because it is new?
KPV is simply less consumer-marketed than better-known peptides. Less marketing is not the same as more or less regulatory certainty - check the dated FDA record rather than a clinic's summary.
Finding licensed care
If you want to talk to someone who can actually evaluate your situation, start with a licensed clinic. We list clinics by city and publish what we verified about each one, with the date we verified it.
Clinics we list: San Diego, CA, Denver, CO, Jacksonville, FL, Sarasota, FL